Skip to main content
Clinical Trials/DRKS00025106
DRKS00025106
Recruiting
未知

E-Stim: Neuromuscular electric stimulation to treat sarcopenia in patients at intensive or intermediate care unit - E-Stim

Innere Medizin III Universtitätklinikum Heidelberg0 sites30 target enrollmentApril 20, 2021
Conditionssarcopenia

Overview

Phase
未知
Intervention
Not specified
Conditions
sarcopenia
Sponsor
Innere Medizin III Universtitätklinikum Heidelberg
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Innere Medizin III Universtitätklinikum Heidelberg

Eligibility Criteria

Inclusion Criteria

  • stay of at least 2 weeks at intensive care unit
  • \- written consent

Exclusion Criteria

  • \- cardiogenic shock
  • \- extracorporeal membrane oxygenation, impella
  • \- myocardial infarction (STEMI) within the last 7 days
  • \- RR \<80 mmHg despite catecholamines
  • \- neuromuscular diseases
  • \- Diabetes
  • \- known myopathy
  • \- adiposity \>II
  • \- abnormality of the skin within the area of Stimulation
  • \- psychiatric diseases, Delirium

Outcomes

Primary Outcomes

Not specified

Similar Trials